Multicomponent, Tumor-Homing Chitosan Nanoparticles for Cancer Imaging and Therapy

Current clinical methods for cancer diagnosis and therapy have limitations, although survival periods are increasing as medical technologies develop. In most cancer cases, patient survival is closely related to cancer stage. Late-stage cancer after metastasis is very challenging to cure because curr...

Descripción completa

Detalles Bibliográficos
Autores principales: Key, Jaehong, Park, Kyeongsoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372610/
https://www.ncbi.nlm.nih.gov/pubmed/28282891
http://dx.doi.org/10.3390/ijms18030594

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372610/
https://www.ncbi.nlm.nih.gov/pubmed/28282891
http://dx.doi.org/10.3390/ijms18030594

Ejemplares similares